Skip to content

A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings

A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03035110
Enrollment
24
Registered
2017-01-27
Start date
2017-04-18
Completion date
2018-05-15
Last updated
2018-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self-Injurious Behavior

Brief summary

The current research is being undertaken as part of a professional doctorate in clinical psychology, which aims to evaluate the feasibility of a group programme to address self-harm within 23 days, to provide evidence for a controlled trial. The intervention will include four group sessions conducted over 2 weeks, based on Dialectical Behavioural Therapy. Specifically the aims are to determine 1) means and a standard deviation for two pre and post treatment outcome measures in order to estimate sample size for the main study, 2) the need for an inpatient intervention for self-harm measured by number of participants eligible and accepting of the treatment, 3) retention of participants for 4 groups given the predicted short stays of patients on wards, and 4) the acceptability of the research process for this client group through feedback.

Interventions

BEHAVIORALDialectical Behavioural Therapy (DBT) based skills groups

Dialectical Behavioural Therapy (DBT) involves skills that help people manage their emotions and tolerate distress. This therapy is found effective in reducing self-harm behaviour for outpatients with Borderline Personality Disorder.

Sponsors

University of Essex
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Participants will be screened by their allocated clinician and included if they are aged between 18-65 * admitted to hospital * have a history of or engaged in at least one episode of self-harm, iv) have capacity to understand the information sheet.

Exclusion criteria

* Participants will be screened by clinicians and they will exclude people if i) they are Non-English speakers (due to translation costs) * they lack the capacity to give informed consent (assessed by their key clinician) * their symptoms prevent them from concentrating for an hour at a time (i.e. severe thought disorder), and therefore not benefiting from the group (assessed by their key clinician)

Design outcomes

Primary

MeasureTime frameDescription
The Inventory of Statements About Self-Injury (ISAS)23 daysISAS is a self-report measure designed to assess the function and frequency of deliberate self-harm. It will be administered pre- and post-intervention.
The Distress Tolerance Scale (DTS)23 daysThe DTS consists of 15 items, which measure a person's appraisal of their emotional distress, their ability to tolerate this distress and any regulation efforts to alleviate it. It will be administered pre- and post-intervention.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026